Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.

Nucor reported quarterly earnings of $3.46 per share which missed the analyst consensus estimate of $3.65. Quarterly sales came in at $8.14 billion, missing the analyst consensus estimate of $8.26 billion, according to data from Benzinga Pro.

Nucor shares tumbled 6.5% to $179.20 on Tuesday.

Here are some other stocks moving in today’s mid-day session.

Gainers

• Cyngn Inc. (NASDAQ:CYN) shares jumped 100% to $0.2419 after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere’s operation in Dubuque, Iowa.
• Pineapple Energy Inc. (NASDAQ:PEGY) shares climbed 50.4% to $0.0689 after falling 10% on Monday.
• Oportun Financial Corporation (NASDAQ:OPRT) gained 46% to $3.29 after the company announced preliminary first-quarter total revenue above estimates.
• Palisade Bio, Inc. (NASDAQ:PALI) shares climbed 44.3% to $7.12 after the company entered a collaboration with Strand Life Sciences.
• KULR Technology Group, Inc. (NASDAQ:KULR) gained 27% to $0.5683 after the company announced it delivered on an immediate basis, a power cell battery deployment order for AI-enabled drone and advanced air mobility missions in Ukraine.
• Smart for Life, Inc. (NASDAQ:SMFL) climbed 20% to $5.22.
• HWH International Inc. (NASDAQ:HWH) rose 19.5% to $1.5307 after declining 3% on Monday.
• SolarMax Technology, Inc. (NASDAQ:SMXT) gained 18.7% to $9.49.
• Hibbett, Inc. (NASDAQ:HIBB) rose 18.4% to $85.85 after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.
• SES AI Corporation (NYSE:SES) gained 17.4% to $1.3499.
• SolarMax Technology, Inc. (NASDAQ:SMXT) rose 15.5% to $9.24.
• FuelCell Energy, Inc. (NASDAQ:FCEL) gained 15.5% to $0.9295.
• Carmell Corporation (NASDAQ:CTCX) climbed 15.2% to $2.20.
• Azitra, Inc. (NYSE:AZTR) shares gained 15% to $0.2244 after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.
• Virgin Galactic Holdings, Inc. (NASDAQ:SPCE) jumped 14.4% to $0.8603.
• 9F Inc. (NASDAQ:JFU) rose 14.3% to $3.29.
• Canaan Inc. (NASDAQ:CAN) gained 14% to $1.05. The company executives announced intentions to purchase at least $2 million of the company's common stock.
• Cartesian Therapeutics, Inc. (NASDAQ:RNAC) jumped 12.7% to $20.59 after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $39 price target.
• Spotify Technology S.A. (NYSE:SPOT) gained 12.3% to $305.73 following first-quarter financial results.
• Heron Therapeutics, Inc. (NASDAQ:HRTX) climbed 11.6% to $2.89 after Capital One initiated coverage on the stock with an Overweight rating and $6 price target.
• Mesoblast Limited (NASDAQ:MESO) gained 9.4% to $6.05.
• Ryder System, Inc. (NYSE:R) rose 9% to $118.82 following better-than-expected quarterly earnings.
• Bloom Energy Corporation (NYSE:BE) jumped 8.8% to $10.15.
• HealthStream, Inc. (NASDAQ:HSTM) surged 7.4% to $25.91 following upbeat quarterly results.
• Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares rose 7% to $0.55 following upbeat quarterly results.
• Roku, Inc. (NASDAQ:ROKU) gained 6.2% to $62.20.

Losers

• Abeona Therapeutics Inc. (NASDAQ:ABEO) fell 48.4% to $3.7950 after the company announced the FDA issued a Complete Response Letter in response to the company’s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.
• Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) shares fell 44.6% to $0.0699. Greenwave Technology Solutions disclosed that it further strengthened its balance sheet by approximately $12 million.
• Lichen China Limited (NASDAQ:LICN) fell 44.4% to $0.5450.
• Tungray Technologies Inc. (NASDAQ:TRSG) shares declined 34.2% to $4.87 after gaining 24% on Monday.
• Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) fell 26.3% to $0.5091.
• Moolec Science SA (NASDAQ:MLEC) fell 24.3% to $1.87. On April 22, Moolec Science said it received approval for its plant-grown animal proteins.
• YY Group Holding Limited (NASDAQ:YYGH) fell 22.4% to $2.25 after tumbling over 27% on Monday. The company, last week, priced its IPO at $4 per share.
• Top Wealth Group Holding Limited (NASDAQ:TWG) dipped 19.7% to $2.0899.
• Comstock Holding Companies, Inc. (NASDAQ:CHCI) declined 18.8% to $6.44.
• SuperCom Ltd. (NASDAQ:SPCB) dipped 18% to $0.2369. SuperCom recently reported better-than-expected quarterly results.
• JetBlue Airways Corporation (NASDAQ:JBLU) declined 16.2% to $6.29 after the company reported first-quarter financial results and issued worse-than-expected Q2 and FY24 Revenue outlook.
• MSCI Inc. (NYSE:MSCI) declined 13% to $448.01 following first-quarter financial results.
• LKQ Corporation (NASDAQ:LKQ) fell 12.6% to $42.78 after the company reported a first-quarter earnings miss and cut its FY24 outlook.
• Simpson Manufacturing Co., Inc. (NYSE:SSD) dipped 11.7% to $163.40 following weak quarterly earnings.
• Jaguar Health, Inc. (NASDAQ:JAGX) shares fell 11.2% to $0.1598 after the company filed for a mixed shelf offering of up to $75 million.
• Xerox Holdings Corporation (NASDAQ:XRX) tumbled 11.1% to $14.60 after the company reported worse-than-expected first-quarter results and reiterated FY24 guidance.
• T2 Biosystems, Inc. (NASDAQ:TTOO) declined 10.4% to $2.83 after gaining around 7% on Monday.
• Sasol Limited (NYSE:SSL) shares fell 10.1% to $7.13 after the company issued its production and sales performance metrics for the nine months ended 31 March, 2024.
• Complete Solaria, Inc. (NASDAQ:CSLR) fell 9.3% to $0.3530 after dipping around 14% on Monday.
• Cleveland-Cliffs Inc. (NYSE:CLF) dipped 7.8% to $19.22 after the company’s reported worse-than-expected first-quarter financial results.
• Phio Pharmaceuticals Corp. (NASDAQ:PHIO) fell 7.1% to $0.77. Phio Pharmaceuticals shares jumped around 33% on Monday after the company announced that its intratumoral injection of murine PH-762 inhibited tumor growth in murine tumor models and may generate memory-specific T cells.
• Calix, Inc. (NYSE:CALX) shares fell 4.1% to $28.34 after the company reported mixed first-quarter financial results and issued second-quarter guidance below estimates.

Read More: Bitcoin Surpasses $66,000; Akash Network, Core Among Top Gainers